LUPINNSELupin Limited· PharmaceuticalsMediumNeutral
Announced Wed, 14 May · 22:40 IST

Lupin Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

At a board meeting on May 14, 2025, Lupin's directors approved three items. First, they appointed Ms. Punita Lal as an Additional Director (Non-Executive, Independent) for a 5-year term from May 14, 2025 to May 13, 2030. She is a former Coca-Cola China and PepsiCo India executive, ex-MD & CEO of NourishCo (Tata-PepsiCo JV), and a past board member of Cipla and CEAT. Second, M/s. Makarand M. Joshi & Co. was named as Secretarial Auditor for five consecutive years covering FY 2025-26 to FY 2029-30. Third, the Board adopted a brand new set of Articles of Association, replacing the old one which was still based on the Companies Act, 1956, to bring it in line with the current Companies Act, 2013. All three items require shareholder approval, with the new AoA needing a Special Resolution.

Likely market impact

These are routine governance and compliance housekeeping items. Adding a seasoned independent director with consumer/FMCG experience strengthens board oversight, and updating the AoA simply brings the company's rulebook up to current law. No direct impact on earnings or share price is expected, though shareholders will get to vote on these proposals.